Pnc Financial Services Group, Inc. Biocryst Pharmaceuticals Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 17,236 shares of BCRX stock, worth $150,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,236
Previous 18,233
5.47%
Holding current value
$150,297
Previous $138,000
6.52%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BCRX
# of Institutions
285Shares Held
171MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$174 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$103 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$79.2 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$77.2 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.62B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...